This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Other. Active years: 2012-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2018
Title: Innovations and Contributions of Inventor Jen-Ai Lee
Introduction
Jen-Ai Lee is a notable inventor based in Taipei, Taiwan. She has made significant contributions to the field of medical technology and treatment methods. With a total of 2 patents, her work focuses on addressing diseases caused by specific pathogenic mechanisms.
Latest Patents
One of her latest patents is titled "Method of treating a patient with a disease caused by a pathogenic mechanism associated with accumulation of methylglyoxal." This invention discloses a method that involves administering a monosaccharide and/or polysaccharide as an active ingredient to decrease the accumulation of di-carbonyl compounds in the human body. The method aims to prevent or treat nephritis and other diseases associated with carbonyl-stress.
Another significant patent is the "Laser capture microdissection system and electric moving stage thereof." This system includes a laser illuminator, a fiber, and an electric moving stage. The design allows for precise microscale shifts, enabling effective dissection and analysis of biological samples.
Career Highlights
Throughout her career, Jen-Ai Lee has worked with various companies, contributing her expertise to advance medical technologies. Her innovative approaches have garnered attention in the scientific community.
Collaborations
Jen-Ai Lee has collaborated with notable individuals in her field, including Chien-Ming Chen and Yi-Chieh Li. These partnerships have further enhanced her research and development efforts.
Conclusion
Jen-Ai Lee's contributions to medical technology through her patents demonstrate her commitment to innovation and improving patient care. Her work continues to influence the field and inspire future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile